Stem cells hold enormous promise in the fight against disease.

The Food and Drug Administration (FDA) recognizes this promise, but also holds tight to procedures that reign in the threat of scams and broken promises when it comes to medicine.

This article says that some in the FDA go beyond the call of duty and instead halt stem cell progress rather than protect the public, and that people who travel internationally for stem cell procedures are, “…demonstrating their own risk preferences: balancing the plausible expected benefits based on what is presently known of the science and the outcomes (in the absence of rigorous trials) against the cost and estimated risk.”

You decide.

Read more:

Robust Cancer Therapies Will Mean a Greater Use of Aggressive Stem Cell Therapies